Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Collegium Pharmaceutical Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Rubric Capital Management David Rosen | 2,333,500 | $75,138,700 | +28% | 1.97% |
2. | Renaissance Technologies Jim Simons | 1,531,498 | $49,314,236 | +8% | 0.08% |
3. | 26,950,000 | $29,698,900 | +165% | 0.84% | |
4. | 23,000,000 | $25,460,195 | 1.32% | ||
5. | GLG Partners Noam Gottesman | 377,425 | $12,153,085 | +45% | 0.03% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$9.18 | 10,000 | Officer | 110,227 | 2017-05-12 | Filing | |
$10.59 | 2,375 | Director | 2,375 | 2016-08-12 | Filing | |
$12.00 | 3,930 | Large Shareholder | 65,270 | 2015-05-12 | Filing | |
$12.00 | 196,070 | Large Shareholder | 3,256,572 | 2015-05-12 | Filing | |
$12.00 | 150,000 | Large Shareholder, Director | 1,887,332 | 2015-05-12 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$36.62 | 9,593 | Officer | 53,816 | 2024-09-13 | Filing | |
$37.46 | 977 | Officer | 119,184 | 2024-09-06 | Filing | |
$39.14 | 2,400 | Officer | 120,161 | 2024-09-05 | Filing | |
$38.18 | 16,848 | Officer | 122,561 | 2024-09-05 | Filing | |
$33.22 | 700 | Officer | 139,409 | 2024-06-03 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 5,786,993 | $178,123,645 | 0% | |
2. | 2,630,478 | $80,966,113 | 1.32% | |
3. | 2,312,786 | $71,187,552 | 0% | |
4. | 2,174,718 | $66,937,820 | 0.18% | |
5. | 1,569,151 | $48,298,467 | 0.03% |